Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 837 results for "Novartis Company"

NPPA slaps Rs 300-crore penalty on Novartis
Business Standard

Novartis India slips on buzz of NPPA penalty

on a media report that the drug pricing regulator has slapped Rs 300 crore penalty on the company. Meanwhile, the BSE Sensex was down 113.78 points, or 0.43%, to 26,183.60. On BSE, so far 23,000 shares were traded in the counter, compared with an average ... Business Standard, 1 week ago
NPPA slaps Rs 300-crore penalty on Novartis Business Standard, 1 week ago

Novartis plunges on NPPA`s penalty

Novartis India , one of the leading pharma companies, witnessed a sharp fall on Monday after National Pharmaceutical Pricing Authority (NPPA) imposed a fine of around Rs 3 billion. The NPPA has imposed a fine for overcharging consumers on sale of Voveran, its ...
 Myiris1 week ago HC asks pharma companies, Centre to resolve the drug pricing  Business Standard1 month ago Novartis India: Outcome of AGM  Money Control2 months ago
MSN India

Novartis India Q1 net up 3 per cent at Rs. 14.31 crore

Standalone net sales of the company declined to Rs. 202.06 crore for the quarter under review Reuters New Delhi: Drug firm Novartis India on Friday reported a 3.17 per cent rise in standalone net profit at Rs. 14.31 crore for the quarter ended June 30, 2014.
 MSN India2 months ago Novartis India Q1 net up 3 pc at Rs 14.31 cr  Business Standard2 months ago
Securities Technology Monitor

MorphoSys gets milestone from Novartis; acquires new technology

German company MorphoSys (FSE: MOR) says it has received a milestone payment from Novartis in connection with the initiation of a Phase I clinical trial of a HuCAL antibody in the field of diabetic eye diseases. This becomes the ninth therapeutic ...
 Pharma Letter12 hours ago Novartis' plaque psoriasis drug candidate AIN457 gets FDA committee recommendation  Pharmaceutical Business Review14 hours ago FDA panel unanimously backs Novartis secukinumab for moderate-to-severe plaque psoriasis  Pharma Letter16 hours ago FDA advisory panel backs Novartis' secukinumab for plaque psoriasis  FirstWord Pharma1 day ago

Novartis to invest in Israel's Gamida Cell, could buy out company

Swiss drugmaker Novartis has agreed to take a 15 per cent stake in Gamida Cell, an Israeli developer of stem cell therapies. JERUSALEM: Swiss drugmaker Novartis has agreed to take a 15 per cent stake in Gamida Cell, an Israeli developer of stem cell ...
 Economic Times2 months ago

Heart drug launch could be 'most exciting ever', says Novartis

BARCELONA (Reuters) - The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday. The Swiss drugmaker impressed ...
 Reuters1 month ago Heart drug launch could be "most exciting ever", says Novartis  First Post.com1 month ago

The Age-Related Macular Degeneration Drug Market Will Grow to Nearly $9 Billion in 2023, Fueled in Part by the Anticipated Launch of the First Therapies for Geographic Atrophy

Company News: Page (1) of 1 - 10/20/14 print page Ophthotech/Novartis's Fovista Will Exceed $500 Million in 2023 Sales as a Treatment for the Wet Form of the Disease, According to Findings from Decision Resources Group (October 20, 2014) ...
 Review Seeker1 day ago
Vietnamese Investment Review

Vietnam Ministry of Health and Novartis form partnership for health

Vietnam's Ministry of Health and Swiss healthcare company Novartis just signed a Memorandum of Understanding (MoU) that aims to enhance the Vietnamese people's access to essential, affordable generic and innovative medicines, and strengthen the ...
 Vietnamese Investment Review3 days ago Novartis Consumer Health, Inc. teams up with entertainer Nick Cannon as he steps off-stage to help America get flu-ready  FierceBiotech1 day ago

Novartis announces collaboration to evaluate Bristol-Myers Squibb's novel immunotherapy drug

Novartis has announced that it has entered into a clinical collaboration with Bristol-Myers Squibb Company to evaluate the safety, tolerability and preliminary efficacy of three molecularly targeted compounds in combination with ...
 MTB Europe5 days ago Bristol-Myers Squibb Announces Collaboration to Evaluate Opdivo nivolumab in Combination with Targeted Therapies from Novartis to Treat Non-Small...  Pharmacy Choice1 day ago

Novartis Employee Pleaded Guilty in Polish Bribery Case

An executive at a pharmaceutical company in Poland who pleaded guilty in a bribery case involving improper payment, works for Novartis , the Swiss drugmaker said on Thursday. Poland's anti-corruption bureau said on Tuesday two women had appeared ...
 Main Justice5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less